Alzheimer Disease

Showing NaN - NaN of 45

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer Trial in United States (ACU193, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • Scottsdale, Arizona
  • +16 more
Feb 1, 2023

Mild Cognitive Impairment, Alzheimer Trial in United States (Donanemab, Aducanumab)

Active, not recruiting
  • Mild Cognitive Impairment
  • Alzheimer Disease
  • Fullerton, California
  • +30 more
Jan 18, 2023

Alzheimer Trial in Worldwide (LY3372689, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • Canoga Park, California
  • +70 more
Jan 18, 2023

Alzheimer Trial in Canada, United States (Donanemab, Placebo, LY3202626)

Completed
  • Alzheimer Disease
  • Phoenix, Arizona
  • +60 more
Sep 19, 2022

Alzheimer, Mild Cognitive Impairment Trial in United States (Florbetapir F 18 PET Scan)

Active, not recruiting
  • Alzheimer Disease
  • Mild Cognitive Impairment
  • Florbetapir F 18 PET Scan
  • Anaheim, California
  • +76 more
Sep 21, 2022

Database to Investigate Blood-Based and Digital Biomarkers in

Recruiting
  • Alzheimer Disease
  • +5 more
  • Biomarker Data Collection
  • Aventura, Florida
  • +15 more
Sep 21, 2022

Alzheimer, Healthy Trial in Japan, United States (LY3372993, Placebo)

Recruiting
  • Alzheimer Disease
  • Healthy
  • Cypress, California
  • +12 more
Aug 17, 2022

Alzheimer Trial in Worldwide (Gantenerumab, Placebo)

Recruiting
  • Alzheimer Disease
  • Tucson, Arizona
  • +247 more
Jul 29, 2022

Alzheimer, Cognitive Decline Trial in Dallas ([18F]AV-1451, Positron Emission Tomography)

Completed
  • Alzheimer Disease
  • Cognitive Decline
  • Dallas, Texas
    UT Southwestern Medical Center
Jul 28, 2022

Alzheimer, Mild Cognitive Impairment, Dementia Trial in Dallas (Active Transcranial direct current stimulation (STARStim 8),

Enrolling by invitation
  • Alzheimer Disease
  • +2 more
  • Active Transcranial direct current stimulation (STARStim 8)
  • Sham Transcranial direct current stimulation (STARStim 8)
  • Dallas, Texas
    UT Southwestern Medical Center
Jul 12, 2022

Alzheimer Trial in United States (Blood Brain Barrier (BBB) Disruption)

Recruiting
  • Alzheimer Disease
  • Blood Brain Barrier (BBB) Disruption
  • Delray Beach, Florida
  • +6 more
Jul 11, 2022

Alzheimer Trial in Canada, Puerto Rico, United States (Simufilam, Placebo)

Recruiting
  • Alzheimer Disease
  • Phoenix, Arizona
  • +76 more
Jul 1, 2022

Alzheimer Trial in Worldwide (Gantenerumab, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • Phoenix, Arizona
  • +156 more
Jul 4, 2022

Alzheimer Trial in Worldwide (Donanemab, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • Hoover, Alabama
  • +282 more
Apr 6, 2022

Alzheimer Trial in Worldwide (COR388 capsule, Placebo capsule)

Completed
  • Alzheimer Disease
  • COR388 capsule
  • Placebo capsule
  • Phoenix, Arizona
  • +92 more
Mar 8, 2022

Alzheimer Trial in Worldwide (GV-971, Placebo)

Recruiting
  • Alzheimer Disease
  • Gilbert, Arizona
  • +170 more
Dec 10, 2021

Alzheimer, Frontotemporal Degeneration (FTD), Lewy Body Dementia (LBD) Trial in Dallas, Edinburg (Problem Solving Training)

Recruiting
  • Alzheimer Disease
  • +5 more
  • Problem Solving Training
  • Dallas, Texas
  • +1 more
Sep 20, 2021

Late Onset Alzheimer's Disease

Recruiting
  • Alzheimer Disease
  • Blood Draw
  • Late Onset Alzheimer's Disease (LOAD) Neuropsychological Battery Test
  • Washington, District of Columbia
  • +11 more
Aug 11, 2021

Alzheimer, Mild Cognitive Impairment, Cognitive Change Trial in Dallas (MyTAP oral appliance plus mouth shield)

Active, not recruiting
  • Alzheimer Disease
  • +4 more
  • MyTAP oral appliance plus mouth shield
  • Dallas, Texas
    Center for BrainHealth, The University of Texas at Dallas
Apr 26, 2021

Alzheimer, Dementia, Alzheimer Type Trial in United States (E2609, Placebo)

Terminated
  • Alzheimer Disease
  • Dementia, Alzheimer Type
  • Bellflower, California
  • +20 more
Mar 4, 2021

Alzheimer Trial in United States (CAD106)

Completed
  • Alzheimer Disease
  • CAD106
  • Costa Mesa, California
  • +7 more
Dec 11, 2020

Alzheimer Trial in Netherlands, United States (DNL747, Placebo)

Completed
  • Alzheimer Disease
  • Miami, Florida
  • +4 more
Feb 25, 2020

That Will Lead to the Early Detection of Alzheimer's Disease

Unknown status
  • Mild Cognitive Impairment
  • Alzheimer Disease
    • Dallas, Texas
      Baylor AT&T Memory Center
    Oct 3, 2019

    Early Onset Alzheimer's Disease Genomic Study

    Unknown status
    • Alzheimer Disease
    • Genetic Testing
    • Dallas, Texas
      Baylor Scott & White AT&T Memory Center
    Oct 3, 2019

    Alzheimer, Mild Cognitive Impairment, Neurodegenerative Diseases Trial in United States (Florbetapir F 18)

    Completed
    • Alzheimer Disease
    • +2 more
    • Florbetapir F 18
    • Phoenix, Arizona
    • +25 more
    Jun 22, 2018